A growing movement within the international medical community is challenging the terminology used to describe one of the world’s most prevalent hormonal disorders. Over 170 million women worldwide live with polycystic ovary syndrome (PCOS), yet patient advocates and healthcare providers argue that the current name fundamentally misrepresents the condition’s systemic complexity.
The Endocrine Society has established working groups to examine alternative terminology that better captures PCOS as a metabolic and hormonal disorder affecting multiple body systems—not merely an ovarian condition. Dr. Helena Teede, director of the Monash Centre for Health Research and Implementation, emphasized that many women with PCOS do not actually have ovarian cysts, yet the misleading name perpetuates diagnostic confusion.
This terminology reform movement represents a significant step toward improving patient understanding, reducing diagnostic delays, and ensuring that healthcare providers recognize PCOS in its full complexity. Major medical organizations are actively reviewing proposed alternatives as part of this important advocacy effort.
Read the full article on GMJ Newsroom.
Was this article helpful?
